Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypersensitivity Reaction
  Free Subscription

Articles published in
Respir Med
    March 2026
  1. KASHANI M, Rostami M, Karimi Darabi M, Jamshidi F, et al
    Explainable artificial intelligence for predicting length of stay and treatment response in pediatric asthma and allergic rhinitis: An irregular fuzzy cellular automata approach across pre- and during-COVID-19 periods.
    Respir Med. 2026;256:108784.
    >> Share

  2. PUTERA AM, Endaryanto A, Irwanto, Sari IL, et al
    Subcutaneous immunotherapy with house dust mite extract in Indonesian children with allergic rhinitis and asthma: A double-blind randomized controlled trial.
    Respir Med. 2026;254:108753.
    >> Share

  3. LOMMATZSCH M, Schmidt O, Timmermann H, Gappa M, et al
    Real-world, long-term effectiveness of dupilumab treatment in patients with severe asthma: 2 years of the ProVENT study.
    Respir Med. 2026 Mar 3:108750. doi: 10.1016/j.rmed.2026.108750.
    >> Share

  4. AIKATERINI S
    Differential diagnosis of severe reactions mimicking or related to allergy and hidden allergens.
    Respir Med. 2026 Mar 2:108732. doi: 10.1016/j.rmed.2026.108732.
    >> Share

  5. LIN L, Zhu F, Xiao J, Yang L, et al
    The minimal clinically important difference of patient-reported outcome measures in adults with asthma: a systematic review.
    Respir Med. 2026 Mar 1:108747. doi: 10.1016/j.rmed.2026.108747.
    >> Share

    February 2026
  6. XING Y, Li Y, Yang J, Yang J, et al
    Mapping the global landscape of biologics in allergic diseases: A bibliometric analysis.
    Respir Med. 2026;254:108734.
    >> Share

  7. KANABAR SS, Pavord ID, Hinks TSC
    Treatable traits and treatment options in asthma.
    Respir Med. 2026 Feb 26:108736. doi: 10.1016/j.rmed.2026.108736.
    >> Share

  8. DA SILVA CRV, Costa EC, Sarinho E, Correia Junior MGA, et al
    Anxiety is associated with asthma severity in adolescents: a school-based epidemiological study.
    Respir Med. 2026 Feb 25:108731. doi: 10.1016/j.rmed.2026.108731.
    >> Share

  9. TANAKA Y, Okamura K, Kaburaki S, Tanaka T, et al
    Utility of MostGraph in Asthma Management: Comparative Study with Cough-Variant Asthma.
    Respir Med. 2026 Feb 24:108728. doi: 10.1016/j.rmed.2026.108728.
    >> Share

  10. AL-IEDE M, Al-Zayadneh E, Fallouh J, Al-Huneidy R, et al
    Temporal trends and projections of asthma in North Africa and Middle East: insights from Global Burden of Disease 2023.
    Respir Med. 2026 Feb 23:108727. doi: 10.1016/j.rmed.2026.108727.
    >> Share

  11. SUMINO K, D'Souza A, Tapp H, Francisco B, et al
    Development and feasibility of provider implementation tools for anti-inflammatory reliever therapy in community asthma practices.
    Respir Med. 2026;254:108717.
    >> Share

  12. KAZDA L, Schlub TE, Guppy M, Forrester M, et al
    Impact of carbon footprint information on inhaler prescribing intentions by general practitioners: protocol for an online factorial randomised experiment.
    Respir Med. 2026;252:108657.
    >> Share

    January 2026
  13. CUNILL V, Andreu V, Iglesias A, Berman M, et al
    Profiles of circulating T follicular helper (cTfh) cell subpopulations in patients with asthma, COPD and asthma-COPD overlap (ACO).
    Respir Med. 2026;253:108672.
    >> Share

  14. NABEH OA, Soliman YMA, Elkorashy RI, Akl Y, et al
    Beyond corticosteroids: A systematic review and meta-analysis of novel therapies for hypersensitivity pneumonitis.
    Respir Med. 2026;252:108661.
    >> Share

  15. MANISCALCO M, Candia C, Ambrosino P, Matera MG, et al
    Fractional Exhaled Nitric Oxide in Monitoring Biological Treatment for Severe Asthma in Adults: Clinical Implications and Future Perspectives.
    Respir Med. 2026 Jan 12:108647. doi: 10.1016/j.rmed.2026.108647.
    >> Share

  16. JANSON C, Malinovschi A, Borres M, Faner R, et al
    Allergic sensitization in asthma and COPD in the NOVELTY study.
    Respir Med. 2026;251:108605.
    >> Share

  17. DOMAGALA-MANCZYK I, Miszczuk-Ciesla M, Maskey-Warzechowska M, Zielecki M, et al
    Limitation of the effectiveness of inhalation training in patients with asthma and COPD.
    Respir Med. 2026;251:108603.
    >> Share

  18. RAMOS D, Francesqui J, Bollo E, Villar A, et al
    Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I.
    Respir Med. 2026;251:108591.
    >> Share

  19. MORIKAWA Y, Morimoto K, Kodani T, Miyahara Y, et al
    Safety and efficacy of a helium-oxygen mix for pediatric respiratory failure associated with anatomical and functional stenotic lesions of the airway: a phase II clinical trial.
    Respir Med. 2026;251:108592.
    >> Share

  20. BANSAL A, Sharma P
    Beyond echoes: Interpreting the septated appearance of lymph nodes in sarcoidosis with endobronchial ultrasound.
    Respir Med. 2026;251:108584.
    >> Share

    December 2025
  21. CHEN F, Lu M, Ye J, Zhang L, et al
    Association between fractional exhaled nitric oxide (FeNO) and blood eosinophil count among children and adolescents with asthma in the United States: a population-based study.
    Respir Med. 2025 Dec 31:108630. doi: 10.1016/j.rmed.2025.108630.
    >> Share

  22. CLARK VL, de Oliveira JM, Gibson PG, McDonald VM, et al
    Prevalence and overlap of treatable traits in severe asthma and COPD: A cross-disease comparison in a tertiary care setting.
    Respir Med. 2025;252:108604.
    >> Share

  23. JESENAK M, Bobcakova A, Golebski K, Krohn IK, et al
    Airway epithelial barrier integrity: an emerging treatable trait in asthma management.
    Respir Med. 2025;252:108579.
    >> Share

  24. SUBOCZ J, Stoup T, Giovannelli J, Bourdin A, et al
    Evolution and factors associated with presenteeism in severe asthma after treatment with biologics.
    Respir Med. 2025;251:108587.
    >> Share

  25. SARAVANAKUMAR T, Mohanakrishnan R
    Effects of neuromuscular breathing exercise with yogic practices on cardiopulmonary variables among women asthmatic patients: A randomized controlled trial.
    Respir Med. 2025;251:108583.
    >> Share

  26. DE SANTANA MBR, Cruz AA, de Araujo JLF, Tugores RM, et al
    Variants in the Glucocorticoid Receptor gene (NR3C1), asthma control and serum cytokine levels.
    Respir Med. 2025;251:108553.
    >> Share

  27. TSUKAO H, Sawahata M, Arai N, Kamei R, et al
    Immune-mediated inflammatory diseases associated with sarcoidosis: A case-control study in Japan.
    Respir Med. 2025;250:108534.
    >> Share

  28. JAMES WE, Chandler J, Benfield K, Pairet S, et al
    A mHealth app for sarcoidosis-associated fatigue: a feasibility randomized control trial.
    Respir Med. 2025;250:108490.
    >> Share

  29. HAMZA YOUSEF MS, Al Azizi HM, Fouad MM
    Point of care ultrasound as a bedside diagnostic tool in acute dyspnea patients in emergency department for timely management.
    Respir Med. 2025;250:108500.
    >> Share

    November 2025
  30. WANG W, Cai H, Fan H, Duan D, et al
    Occurrence of allergic bronchopulmonary aspergillosis in Chinese adults with asthma and COPD comorbidity.
    Respir Med. 2025;251:108547.
    >> Share

  31. SAGAYARAJ MJ, Panneerselvam S, Jeganathan HR, Theivendren P, et al
    Advances in Asthma-COPD Overlap Treatment: A Comprehensive Review of Therapeutic Approaches.
    Respir Med. 2025 Nov 26:108542. doi: 10.1016/j.rmed.2025.108542.
    >> Share

  32. CHOI YM, Womble JT, Greene ST, Vanetta C, et al
    Short-term impact of bariatric surgery on systemic inflammation in patients with asthma.
    Respir Med. 2025;250:108540.
    >> Share

  33. STRIDSMAN C, Konradsen JR, Andersson N, Vanfleteren LEGW, et al
    Extremely-to-very preterm birth and being small for gestational age increase the risk of severe airflow obstruction in patients with asthma.
    Respir Med. 2025;250:108536.
    >> Share

  34. ZHAO L, Chen G, Huang C, Kong W, et al
    Machine learning for prediction of eosinophilic asthma using clinical indicators as an alternative to induced sputum.
    Respir Med. 2025 Nov 19:108528. doi: 10.1016/j.rmed.2025.108528.
    >> Share

  35. CHEN F, Ye J, Zhang L, Lin BQ, et al
    Associations of serum cotinine with asthma risk in US children: a mediation analysis of body mass index.
    Respir Med. 2025 Nov 12:108502. doi: 10.1016/j.rmed.2025.108502.
    >> Share

  36. BARRY LE, Habib M, Heaney LG, Nianogo RA, et al
    Socioeconomic Disparities in Inpatient Outcomes Among US Pediatric Asthma Hospitalizations.
    Respir Med. 2025 Nov 11:108501. doi: 10.1016/j.rmed.2025.108501.
    >> Share

  37. CHEN L, Chen H, Chen Z, Zhang K, et al
    Visceral obesity, partly mediated by a reduction in HDL-C, increases the risk of asthma: Insights from NHANES and Mendelian randomization studies.
    Respir Med. 2025;249:108482.
    >> Share

  38. QIN L, Na L, Liu JL, Tang LF, et al
    Risk factors and strategies associated with subcutaneous allergen immunotherapy in children.
    Respir Med. 2025 Nov 4:108461. doi: 10.1016/j.rmed.2025.108461.
    >> Share

  39. BERTHON BS, Williams LM, McLoughlin RF, Nichol KS, et al
    Pilot investigation of an oligosaccharide blend in adults with asthma - a double-blind, randomised, placebo-controlled, 4-arm crossover trial.
    Respir Med. 2025 Nov 3:108474. doi: 10.1016/j.rmed.2025.108474.
    >> Share

  40. ZHANG S, Shen K, Sun B, Liu B, et al
    Associations of the prevalence of chronic respiratory diseases and mortality with blood furan levels: a population-based study.
    Respir Med. 2025;248:108422.
    >> Share

  41. TAHMAZ T, Aslan GK, Yeldan I, Okumus NG, et al
    Comparison of the effects of one-legged and two-legged exercise training on exercise capacity and fatigue in patients with sarcoidosis.
    Respir Med. 2025;248:108380.
    >> Share

  42. LUO W, Zheng X, Zhang J, Li A, et al
    Component-resolved diagnostics study on nut sensitization and cross-reactivity in China.
    Respir Med. 2025;248:108365.
    >> Share

  43. CAZZOLA M, Hanania NA, Rogliani P
    Comorbidities as treatable traits of chronic airway diseases.
    Respir Med. 2025;248:108333.
    >> Share

  44. AGUSTI A, Gibson P, Cazzola M
    Treatable Traits. Why, What, How?
    Respir Med. 2025;249:108421.
    >> Share

    October 2025
  45. KOWALCZYK ET, Medubi KM, Meyer MJ, Toriola MA, et al
    Development of novel pegylated imidazobenzodiazepines as inhaled asthma drug candidates.
    Respir Med. 2025 Oct 22:108449. doi: 10.1016/j.rmed.2025.108449.
    >> Share

  46. MACKLE R, Crespo-Gonzalez C, Gray M, Chan M, et al
    Implementing enhanced paediatric asthma care in rural Australia: Qualitative insights from healthcare professionals.
    Respir Med. 2025;249:108444.
    >> Share

  47. DA SILVA LIMA D, Rechenmacher C, Bernardi J, Velleda de Morais R, et al
    SMAD3 gene methylation profile and asthma in childhood: A longitudinal approach.
    Respir Med. 2025;249:108424.
    >> Share

  48. SUTER P, Greig R, Kuo CR, Chan R, et al
    Comparison of oscillometry ratios between IOS and AOS in patients with asthma and COPD.
    Respir Med. 2025 Oct 7:108402. doi: 10.1016/j.rmed.2025.108402.
    >> Share

  49. ARARAT E, Rastogi D, Martin BC
    Metformin use is associated with reduced systemic steroid courses among pediatric asthma patients with diabetes or elevated blood glucose levels.
    Respir Med. 2025 Oct 6:108403. doi: 10.1016/j.rmed.2025.108403.
    >> Share

  50. OTTEN B, Weinberg D, Gregoski MJ, James WE, et al
    Management of anti-drug antibodies against TNF-inhibitors in sarcoidosis patients.
    Respir Med. 2025;247:108301.
    >> Share

  51. VERMA B, Kumar N, Ashique S, Debnath B, et al
    Probiotics: An adjuvant treatment strategy for chronic respiratory diseases.
    Respir Med. 2025;247:108268.
    >> Share

    September 2025
  52. BROZEK G, Nowak B, Prendergast C, Gil A, et al
    Thirty year trends in childhood asthma and allergic conditions in Poland.
    Respir Med. 2025;248:108379.
    >> Share

  53. ALAM ABMN, Gill N, AlAshoor M, Cherif I, et al
    SGLT2-inhibitors and asthma outcomes in type 2 diabetes: Insights from a large multicenter study.
    Respir Med. 2025;248:108357.
    >> Share

  54. FABOZZI A, Bouloukaki I, Bonini M, Schiza SE, et al
    Asthma-OSA overlap syndrome: A distinct endophenotype?
    Respir Med. 2025;248:108344.
    >> Share

  55. HARVEY ES, Hamada Y, Hiles SA, Langton D, et al
    Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.
    Respir Med. 2025 Sep 3:108340. doi: 10.1016/j.rmed.2025.108340.
    >> Share

  56. ZHOU Y, Yao Q, Chen X, Yu D, et al
    Airway involvement in pulmonary sarcoidosis: Clinical and CT features.
    Respir Med. 2025;246:108207.
    >> Share

    August 2025
  57. CELEBI SOZENER Z, Ozdel Ozturk B, Sahinoglu E, Koyluce S, et al
    Benralizumab In Severe Eosinophilic Asthma: A Real-Life Data From Turkiye.
    Respir Med. 2025 Aug 28:108332. doi: 10.1016/j.rmed.2025.108332.
    >> Share

  58. OLIVEIRA JM, Urroz Guerrero PD, Lewthwaite H, Clark VL, et al
    Safety of the 6-minute walk test in adults with severe asthma.
    Respir Med. 2025 Aug 21:108316. doi: 10.1016/j.rmed.2025.108316.
    >> Share

  59. BRIDEVAUX PO, Bourdin A, VAN Ganse E
    Substantial Reduction in Oral Corticosteroid Use After Biologics Initiation in Severe Asthma: An Analysis Based on Swiss Pharmacy Data.
    Respir Med. 2025 Aug 21:108312. doi: 10.1016/j.rmed.2025.108312.
    >> Share

  60. GREIG R, Suter P, Chan R, Lipworth B, et al
    Impact of dupilumab on oscillometry and spirometry derived ratios in severe refractory asthma.
    Respir Med. 2025;247:108315.
    >> Share

  61. HOGAARD NV, Sigsgaard T, Agertoft L, Halken S, et al
    Effect of indoor environmental interventions in the home on asthma in children and adolescents: A systematic review.
    Respir Med. 2025 Aug 5:108299. doi: 10.1016/j.rmed.2025.108299.
    >> Share

  62. PATEL C, Sheth V, Koppula R, Kumar A, et al
    Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometa
    Respir Med. 2025;247:108293.
    >> Share

  63. TU D, Ju S, Xue Y, Xie W, et al
    Association between asthma and advanced cardiovascular-kidney-metabolic syndrome in U.S. adults, a cross-sectional study from NHANES 2011-2023.
    Respir Med. 2025;247:108288.
    >> Share

  64. PHAM TQ, Delorme L, Cortaredona S, Ranque S, et al
    Pulmonary Aspergillosis: Epidemiology and unresolved diagnostic challenges - insights from a two-year retrospective cohort study in Marseille.
    Respir Med. 2025;245:108206.
    >> Share

  65. HU Y, Hu Y, Dong M, Zheng S, et al
    Integrating clinical phenotypes, impulse oscillometry and fractional exhaled nitric oxide: a robust machine learning model for early asthma prediction in preschool children.
    Respir Med. 2025 Aug 1:108290. doi: 10.1016/j.rmed.2025.108290.
    >> Share

    July 2025
  66. TIRELLI C, Parazzini EM, Sacchi L, Carone G, et al
    Forced Oscillatory Technique R5-19 values correlate with spirometry FEV1/FVC in severe eosinophilic asthma. An observational, prospective, cohort study.
    Respir Med. 2025 Jul 16:108260. doi: 10.1016/j.rmed.2025.108260.
    >> Share

  67. PARK HJ, Lee CH, Lee JK, Kim DK, et al
    Radiologic emphysema predicts accelerated lung function decline in patients with asthma.
    Respir Med. 2025;247:108261.
    >> Share

  68. TIAN C, Xiong S, Song X, Li S, et al
    Spirometry and impulse oscillometry in the diagnosis of cough variant asthma in children.
    Respir Med. 2025;246:108255.
    >> Share

  69. KOH MS, Xu X, Wei Lam SS, Wu JT, et al
    Public health insights of patients with asthma receiving primary, specialist or mixed care in Singapore using data from the SDG-CARE Asthma Registry.
    Respir Med. 2025 Jul 11:108252. doi: 10.1016/j.rmed.2025.108252.
    >> Share

  70. ACHTERBOSCH M, Hansen CME, Brand PLP, van Dijk L, et al
    Shared decision making and inhaled medication adherence in patients with COPD, asthma and cystic fibrosis: a systematic review.
    Respir Med. 2025 Jul 11:108251. doi: 10.1016/j.rmed.2025.108251.
    >> Share

  71. KISIEL MA, Zhou X, Fundberg I, Barrling A, et al
    Mortality and its predictive factors in participants with asthma: a 26-year follow-up.
    Respir Med. 2025;246:108253.
    >> Share

  72. BRAIDO F, Beeh KM, Serrano CC, Dinh-Xuan AT, et al
    Real-world use of beclometasone dipropionate and formoterol fumarate NEXThaler(R) and asthma control among adult asthmatic patients in Europe: The results of the NEWTON Study.
    Respir Med. 2025 Jul 9:108224. doi: 10.1016/j.rmed.2025.108224.
    >> Share

  73. DIEZ SIERRA J, Medina Gallardo JF, Munoz Sanchez B, Leon Lloreda A, et al
    FEV(1) Decline and Clinical Predictors in Asthma after 10 Years of Follow-Up: BMI as a Modifiable Risk Factor.
    Respir Med. 2025 Jul 4:108247. doi: 10.1016/j.rmed.2025.108247.
    >> Share

  74. ALIPOUR P, Nery PB, Beanlands RS, Wiefels C, et al
    Durable remission of cardiac sarcoidosis following discontinuation of methotrexate: A prospective cohort study.
    Respir Med. 2025;243:108126.
    >> Share

  75. HANSEN H, Godtfredsen N, Ulrik CS, Hansen J, et al
    Physical activity levels in Danish adults with and without asthma - A national recurrent cross-sectional case-control study from 2010 to 2021.
    Respir Med. 2025 Jul 1:108240. doi: 10.1016/j.rmed.2025.108240.
    >> Share

    June 2025
  76. ZHU W, Chen K, Xiang Y, Shi J, et al
    Real-World Respiratory Effectiveness of mepolizumab in Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis.
    Respir Med. 2025 Jun 26:108223. doi: 10.1016/j.rmed.2025.108223.
    >> Share

  77. ANTAO J, Rodrigues G, Deng Q, Baak BN, et al
    Trends in initial pharmacological treatment of asthma in primary care (2010-2021): A population-based study using the PHARMO data network.
    Respir Med. 2025;246:108222.
    >> Share

  78. ZHENG X, Jiang H, Cui R, Cai A, et al
    From Itchy Skin to Wheezing: Potential biomarkers and targeted drugs for Atopic Dermatitis and Asthma in Children.
    Respir Med. 2025 Jun 13:108212. doi: 10.1016/j.rmed.2025.108212.
    >> Share

  79. HANSEN S, Hakansson KEJ, Soendergaard MB, Bjerrum AS, et al
    Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register.
    Respir Med. 2025 Jun 11:108203. doi: 10.1016/j.rmed.2025.108203.
    >> Share

  80. PINI L, Caminati M, Maule M, Bagnasco D, et al
    ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up.
    Respir Med. 2025;245:108198.
    >> Share

  81. BRAUNWALDER C, Ertl J, Wullschleger M, Timm E, et al
    Efficacy and safety of phytotherapy and anthroposophic medicine in bronchial asthma: A systematic review.
    Respir Med. 2025 Jun 7:108202. doi: 10.1016/j.rmed.2025.108202.
    >> Share

  82. TAY TR, Pang E, Liew MF, Tiew PY, et al
    Ethnic variation in South East Asian patients with Severe Asthma: A First Look at the Singapore Severe Asthma Registry (SSAR) and implications on clinical practice.
    Respir Med. 2025 Jun 5:108199. doi: 10.1016/j.rmed.2025.108199.
    >> Share

  83. COOPER DH, Akbarian N, Aaron SD, Luks V, et al
    Glucagon-like Peptide 1 (GLP-1) Receptor Agonists and Asthma and COPD Exacerbations in Adults with Diabetes: A Systematic Review.
    Respir Med. 2025 Jun 4:108197. doi: 10.1016/j.rmed.2025.108197.
    >> Share

  84. LI H, Huang X, Wei Z, Chen Z, et al
    Unveiling genetic links: GSDMB polymorphisms and asthma susceptibility in the Zhuang Nationality of Guangxi.
    Respir Med. 2025;245:108176.
    >> Share

    May 2025
  85. HANANIA NA, Stanford R, Rendon A, Gemicioglu B, et al
    Comparative effectiveness of inhaled fluticasone propionate/salmeterol and budesonide/formoterol fixed-dose combinations in asthma control - a retrospective United States database analysis.
    Respir Med. 2025 May 28:108172. doi: 10.1016/j.rmed.2025.108172.
    >> Share

  86. ZHANG X, Zhang X, Wan Y, Xu D, et al
    The association between alpha-1-acid glycoprotein and asthma in United States: a cross-sectional study from NHANES.
    Respir Med. 2025;245:108174.
    >> Share

  87. COTTINI M, Poto R, Bhattacharjee A, Galant S, et al
    Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma.
    Respir Med. 2025 May 27:108180. doi: 10.1016/j.rmed.2025.108180.
    >> Share

  88. XIANG J, Cui M
    Neutrophil Extracellular Traps and neutrophilic asthma.
    Respir Med. 2025 May 12:108150. doi: 10.1016/j.rmed.2025.108150.
    >> Share

  89. LEMACON C, Lopes AA
    Inhalers or nebulisation of salbutamol in childhood asthma exacerbations in emergency departments.
    Respir Med. 2025 May 8:108152. doi: 10.1016/j.rmed.2025.108152.
    >> Share

  90. MOERMANS C, Decerf N, Javaux N, Onssels A, et al
    High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor.
    Respir Med. 2025 May 7:108151. doi: 10.1016/j.rmed.2025.108151.
    >> Share

  91. WENNERGREN G, Lindberg A, Kauppi P, Kankaanranta H, et al
    Glimpses of diagnostic tools and treatment of asthma in Sweden, Norway, and Finland from a medico-historical perspective.
    Respir Med. 2025;243:108139.
    >> Share

  92. BULKHI AA, Elkkari A, Alghamdi BJ, Mahboub B, et al
    Defining Clinical Remission in Severe Asthma: Expert Opinion from the Gulf Region Using the Modified Delphi Method.
    Respir Med. 2025 May 3:108132. doi: 10.1016/j.rmed.2025.108132.
    >> Share

  93. DEHARA M, Nguyen NV, Arkema EV
    Smoking and the risk of sarcoidosis: a systematic review and meta-analysis.
    Respir Med. 2025;241:108089.
    >> Share

  94. LUNDE AG, Henriksen AH, Sorger H, Naustdal T, et al
    Prevalence, incidence, and mortality associated with sarcoidosis over three decades in the HUNT Study in Norway.
    Respir Med. 2025;241:108049.
    >> Share

    April 2025
  95. TSE SM, Babatounde AK, Drouin O, Radhakrishnan D, et al
    The association between the stringency of COVID-19 public health mitigation strategies and pediatric asthma-related hospitalizations in Canada: an ecological study over 2 years.
    Respir Med. 2025;243:108125.
    >> Share

  96. HUETHER KM, Lamb JM, Skelly J, Brigham E, et al
    Omega-3 Fatty Acid Intake Potentiates Bronchodilator Response in Patients with Obesity and Poorly Controlled Asthma.
    Respir Med. 2025 Apr 26:108131. doi: 10.1016/j.rmed.2025.108131.
    >> Share

  97. GHERASIM A, Dietsch F, Odul F, Riff T, et al
    Efficacy of air cleaners to reduce allergic responses to cat: a randomized clinical trial using an environmental exposure chamber.
    Respir Med. 2025 Apr 15:108105. doi: 10.1016/j.rmed.2025.108105.
    >> Share

  98. UNSAL H, Karaguzel D, Sarac BE, Aytekin ES, et al
    Inflammatory and oxidative stress markers in serum, urine and exhaled breath condensate: Relationship between asthma and obesity in children.
    Respir Med. 2025;242:108096.
    >> Share

  99. BAGUST A, Zhao C, Troy L, Van Buskirk J, et al
    Geographic variability of interstitial lung disease diagnoses and impact of air pollution on disease outcomes.
    Respir Med. 2025;239:107996.
    >> Share

  100. DY ABC, Voraphani N, Spangenberg A, Belinsky SA, et al
    Circulating CC16, immune response to Mycoplasma pneumoniae and lung function: a population-based, multi-cohort study.
    Respir Med. 2025;240:108044.
    >> Share

  101. ZHANG S, Lin J
    Association of circadian syndrome and lung health: A population-based cohort study.
    Respir Med. 2025;240:108031.
    >> Share

    March 2025
  102. STATEN T, Liu PH, Holt C, Alismail A, et al
    Effectiveness Of A Respiratory Therapist-Led, Community-Based Asthma Program In An Under resourced Rural Border Town In California.
    Respir Med. 2025 Mar 29:108071. doi: 10.1016/j.rmed.2025.108071.
    >> Share

  103. MENZELLA F, Cottini M, Lombardi C, Senna G, et al
    A Real-world Study on Tezepelumab Effectiveness in Severe Asthma Focusing on Small Airway Dysfunction.
    Respir Med. 2025 Mar 25:108054. doi: 10.1016/j.rmed.2025.108054.
    >> Share

  104. ECK S, Baumgartel A, Hapfelmeier A, Linde K, et al
    Effectiveness of an online asthma education program in adults with asthma in general practice: Results from a cluster randomised controlled trial.
    Respir Med. 2025;240:108041.
    >> Share

  105. GUINOSSI RM, Bertagni Mingotti CF, Burch MO, Teixeira Soares LA, et al
    Residential greenness, respiratory symptoms and lung function in children, adolescents and adults with asthma: a cross-sectional study.
    Respir Med. 2025 Mar 11:108038. doi: 10.1016/j.rmed.2025.108038.
    >> Share

  106. PELGROM AT, de Jongh IFHC, van den Aardweg JG, van Veen IHPAA, et al
    Analysis of the breathing pattern in patients with asthma during physical exercise: a cross-sectional study.
    Respir Med. 2025 Mar 11:108037. doi: 10.1016/j.rmed.2025.108037.
    >> Share

  107. ORTIZ J, Staggers KA, Adrish M, Hanania NA, et al
    Asthma outcomes in a safety net hospital system: A comparative study to a national cohort.
    Respir Med. 2025;240:108032.
    >> Share

  108. ZHAO C, Wang L, Zhang L, Wang Q, et al
    Asthma Exacerbation Comorbidity Index (AECI): Predicting In-Hospital Adverse Outcomes.
    Respir Med. 2025 Mar 3:108024. doi: 10.1016/j.rmed.2025.108024.
    >> Share

  109. OTTESEN TG, Rovsing AH, Ulrik CS
    Local and systemic adverse effects of inhaled corticosteroids - Does ciclesonide differ from other inhaled corticosteroids?
    Respir Med. 2025;238:107962.
    >> Share

  110. KINOSHITA Y, Hirai C, Hara K, Takenaka S, et al
    Diagnostic and prognostic implications of a deep suprasternal notch in idiopathic pleuroparenchymal fibroelastosis.
    Respir Med. 2025;238:107986.
    >> Share

  111. NAKAMURA J, Sato T, Ohira H, Yoshikawa S, et al
    Prevalence, incidence, and clinical features of cardiac involvement in patients with pulmonary sarcoidosis.
    Respir Med. 2025;238:107954.
    >> Share

    February 2025
  112. SUN C, Li N, Xiao X, Zhang Q, et al
    Association between lipid accumulation products and asthma among adults: Data from National Health and Nutrition Examination Survey (NHANES) 2003-2018.
    Respir Med. 2025;240:108017.
    >> Share

  113. PORTACCI A, Iorillo I, Quaranta VN, Amendolara M, et al
    Diaphragm function in patients with asthma and healthy controls: a cross-sectional study.
    Respir Med. 2025 Feb 18:108008. doi: 10.1016/j.rmed.2025.108008.
    >> Share

  114. JIANG P, Lu H, Jiang Y, Li F, et al
    Association between the triglyceride-glucose index and mortality in the asthma population.
    Respir Med. 2025 Feb 8:107989. doi: 10.1016/j.rmed.2025.107989.
    >> Share

  115. GARCIA-MOGUEL I, Martinez-Mesa A, Andujar-Espinosa R, Diaz-Campos R, et al
    The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: An ORBE II subanalysis.
    Respir Med. 2025;237:107940.
    >> Share

  116. SAPORITI JM, de Holanda TA, Torino GG, Boscato N, et al
    Obstructive sleep apnoea-associated factors in children and adolescents diagnosed by polysomnography: A scoping review.
    Respir Med. 2025;237:107942.
    >> Share

    January 2025
  117. TIOTIU A, Migueres N, Gonzalez-Barcala FJ, Roux P, et al
    Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps.
    Respir Med. 2025;238:107979.
    >> Share

  118. OKAY B, Hatipoglu HU, Okay ZU, Sahin K, et al
    COMPARING MESH AND COMPRESSOR NEBULIZERS IN PULMONARY FUNCTION TEST IN PEDIATRIC ASTHMA ATTACKS: A DOUBLE-BLIND RANDOMIZED COMPARATIVE CLINICAL TRIAL.
    Respir Med. 2025 Jan 28:107966. doi: 10.1016/j.rmed.2025.107966.
    >> Share

  119. CAZZOLA M, Calzetta L, Matera MG, Rogliani P, et al
    Challenges in treating patients with comorbid asthma and bronchiectasis.
    Respir Med. 2025 Jan 21:107957. doi: 10.1016/j.rmed.2025.107957.
    >> Share

  120. COSINI FF, Bagnasco D, Braido F, Canonica GW, et al
    Background therapy in severe asthma on monoclonal antibody treatment in real life.
    Respir Med. 2025;237:107944.
    >> Share

    December 2024
  121. FERREIRA PM, Machado F, Coelho DB, Alexandre AT, et al
    Clinical impact of pre-determined guideline selection for the diagnosis of fibrotic hypersensitivity pneumonitis.
    Respir Med. 2024 Dec 31:107925. doi: 10.1016/j.rmed.2024.107925.
    >> Share

  122. BELHASSEN M, Marchal C, Deygas F, Jacoud F, et al
    In patients with asthma, obesity status is associated with poor control and high exacerbation rates, which are reversed after bariatric surgery.
    Respir Med. 2024;236:107917.
    >> Share

  123. AJAZ M, Singh I, Vugic L, Jani R, et al
    The interplay of plant-based antioxidants, inflammation, and clinical outcomes in asthma: A systematic review.
    Respir Med. 2024;236:107918.
    >> Share

  124. SHALMON T, Freund O, Wand O, Schneer S, et al
    Hypersensitivity Pneumonitis Radiologic Features in Interstitial Lung Diseases.
    Respir Med. 2024 Dec 2:107901. doi: 10.1016/j.rmed.2024.107901.
    >> Share

  125. DONOHUE P, Connolly M, D'Alfonso M, Jackson G, et al
    Peripheral Airways Dysfunction Measured by Oscillometry Differentiates Asthma from Inducible Laryngeal Obstruction.
    Respir Med. 2024 Dec 2:107905. doi: 10.1016/j.rmed.2024.107905.
    >> Share

  126. PETAT H, Marguet C
    Three-year outcome of a very young severe uncontrolled preschool wheezers cohort, a real-life study.
    Respir Med. 2024;235:107875.
    >> Share

    November 2024
  127. GEMICIOGLU B, Gokmen D, Can A, Sevinc C, et al
    Factors Influencing the Prescription of Add-on Long-Acting Muscarinic Antagonists in Real-World Asthma Management: Insights from a National Registry.
    Respir Med. 2024 Nov 29:107883. doi: 10.1016/j.rmed.2024.107883.
    >> Share

  128. FARSHID S, Buckland BC, Shanmuganathan S, Low GK, et al
    End-tidal carbon dioxide, a point-of-care biomarker to assess severity in acute asthma: A systematic review.
    Respir Med. 2024 Nov 29:107891. doi: 10.1016/j.rmed.2024.107891.
    >> Share

  129. YIGIT E, Yuksel H, Ulman C, Yilmaz O, et al
    NASAL EFFECTS OF ENVIRONMENTAL TOBACCO SMOKE EXPOSURE IN CHILDREN WITH ALLERGIC RHINITIS.
    Respir Med. 2024 Nov 27:107886. doi: 10.1016/j.rmed.2024.107886.
    >> Share

  130. YASUI H, Oishi K, Nihashi F, Furuhashi K, et al
    Factors associated with uncontrolled severe asthma in the biologic era.
    Respir Med. 2024;236:107881.
    >> Share

  131. ERRASTI VIADER J, Martinez Gonzalez MA, Campo Ezquibela A, Bes-Rastrollo M, et al
    Dietary patterns and asthma incidence in adult population. Systematic review and meta-analysis.
    Respir Med. 2024 Nov 19:107861. doi: 10.1016/j.rmed.2024.107861.
    >> Share

  132. SESHADRI N, Faig W, Young LR, Hill DA, et al
    Risk Factors for Hospitalization in Subspecialty Patients with Severe Persistent Asthma.
    Respir Med. 2024 Nov 15:107867. doi: 10.1016/j.rmed.2024.107867.
    >> Share

  133. GOMEZ LF, Kinnee E, Kaufman JD, Young MT, et al
    Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial.
    Respir Med. 2024;234:107853.
    >> Share

  134. GRASL MT, Agusti A, Azizzadeh M, Karimi A, et al
    Prevalence and etiotypes of persistent airflow obstruction in the general population across the lifetime.
    Respir Med. 2024;233:107779.
    >> Share

  135. EASTERLING R, James WE
    Overlap syndromes in sarcoidosis: Unveiling the masquerader.
    Respir Med. 2024;234:107841.
    >> Share

    October 2024
  136. CAZZOLA M, Ora J, Calzetta L, Rogliani P, et al
    beta-Blockers and Asthma: Surprising Findings from the FAERS Database.
    Respir Med. 2024 Oct 26:107849. doi: 10.1016/j.rmed.2024.107849.
    >> Share

  137. WULFECK MK, Mummy DG, Zhang S, Kadi D, et al
    Hyperpolarized (129)Xe MRI and spectroscopy of gas exchange abnormalities in chronic hypersensitivity pneumonitis.
    Respir Med. 2024;234:107827.
    >> Share

  138. ZHENG K, Tang L, Wang X, Chen L, et al
    The risk factors for chronic cough in children: A meta-analysis covering five continents.
    Respir Med. 2024;232:107752.
    >> Share

  139. WU WW
    Association of naples prognostic score and lung health: A population-based study.
    Respir Med. 2024;232:107751.
    >> Share

    September 2024
  140. HAMELMANN E, Csonka P, Roberts G, Vogelberg C, et al
    High burden of respiratory allergy in children warrants early identification and treatment with allergen immunotherapy.
    Respir Med. 2024 Sep 24:107812. doi: 10.1016/j.rmed.2024.107812.
    >> Share

  141. HAKANSSON KEJ, Alabdulkarim N, Guerrero SC, Backer V, et al
    Real-world phenotyping and risk assessment of childhood asthma burden using national registries.
    Respir Med. 2024;234:107808.
    >> Share

  142. NOPSOPON T, Brown A, Hahn G, Rank M, et al
    Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics.
    Respir Med. 2024 Sep 9:107802. doi: 10.1016/j.rmed.2024.107802.
    >> Share

  143. QUEZADA WA, Angulo D, Murray S, Joo M, et al
    Exacerbation-like events in the 12 months prior to identification of chronic respiratory conditions in a primary care population.
    Respir Med. 2024;231:107695.
    >> Share

    August 2024
  144. WHARTON R, Mathis N, Wang JG, Meislin R, et al
    Feasibility of Remote Spirometry Monitoring of Asthma in Pregnancy.
    Respir Med. 2024 Aug 24:107782. doi: 10.1016/j.rmed.2024.107782.
    >> Share

  145. TERL M, Diamant Z, Kosturiak R, Jesenak M, et al
    Choosing the right biologic treatment for individual patients with severe asthma - lessons learnt from Picasso.
    Respir Med. 2024 Aug 22:107766. doi: 10.1016/j.rmed.2024.107766.
    >> Share

  146. NORWEG A, Oh C, Nolan A
    Onion Consumption is Protective Against Asthma Risk in Children: ROAD to Health Population-based Cohort Study.
    Respir Med. 2024 Aug 11:107767. doi: 10.1016/j.rmed.2024.107767.
    >> Share

  147. KARJALAINEN J, Vartiainen V, Tikkakoski A, Malmberg LP, et al
    Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.
    Respir Med. 2024;230:107693.
    >> Share

    July 2024
  148. BULT L, Thelen JC, Rauh SP, Veen JCCMI', et al
    Dupilumab responder types and predicting factors in patients with type 2 severe asthma: a real-world cohort study.
    Respir Med. 2024 Jul 9:107720. doi: 10.1016/j.rmed.2024.107720.
    >> Share

  149. LOCCI C, Puci MV, Saderi L, Sotgiu G, et al
    The complex link between sleep-disordered breathing and asthma control in pediatric patients: a cross-sectional study.
    Respir Med. 2024 Jul 2:107730. doi: 10.1016/j.rmed.2024.107730.
    >> Share

  150. SORIANO JB, Polverino F
    Sexual activity and respiratory disease: A systematic review.
    Respir Med. 2024;228:107665.
    >> Share

    June 2024
  151. VISSER CD, Faay MRA, Ozdemir A, Guchelaar HJ, et al
    Short-acting beta(2)-agonists (SABA) overuse in asthma and patients' perceptions for this behavior.
    Respir Med. 2024 Jun 25:107723. doi: 10.1016/j.rmed.2024.107723.
    >> Share

  152. PACKHAM S, Odling M, Bossios A, Konradsen JR, et al
    Adherence to inhaled corticosteroid therapy and treatment escalation in the Swedish adult asthma population.
    Respir Med. 2024;231:107714.
    >> Share

  153. MARTINEZ-GONZALEZ CL, Camargo Fajardo MCC, Martinez-Ortiz EJ, Segura Medina P, et al
    A soft systems approach of asthma management in children based on therapeutic education and e-learning.
    Respir Med. 2024 Jun 4:107691. doi: 10.1016/j.rmed.2024.107691.
    >> Share

  154. SMITH H, Easterling R, Ma J, Moodabagil M, et al
    Sarcoid-like reactions to immune checkpoint inhibitors: Incidence, treatment course, and impact on cancer progression and survival.
    Respir Med. 2024;227:107640.
    >> Share

  155. ZELL-BARAN LM, Krefft SD, Strand M, Rose CS, et al
    Longitudinal changes in lung function following post-9/11 military deployment in symptomatic veterans.
    Respir Med. 2024;227:107638.
    >> Share

    May 2024
  156. AL-AHMAD M, Al Zaabi A, Madkour A, Alqaraghuli HA, et al
    Expert Consensus on Oral Corticosteroids Stewardship for the Treatment of Severe Asthma in the Middle East and Africa.
    Respir Med. 2024 May 21:107674. doi: 10.1016/j.rmed.2024.107674.
    >> Share

  157. BETANCOR D, Barroso B, Valverde-Monge M, Gomez-Lopez A, et al
    The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria.
    Respir Med. 2024;226:107609.
    >> Share

  158. VAN WOENSEL J, Koopman B, Schiefer M, van Kan C, et al
    Organ involvement in newly diagnosed sarcoidosis patients in the Netherlands: The first large European multicentre prospective study.
    Respir Med. 2024;226:107608.
    >> Share

  159. HARPER LJ, Tauquir A, Huang S, Wang X, et al
    Comparison of organ involvement clusters in Black and White American sarcoidosis patients from a prospectively collected patient registry.
    Respir Med. 2024;226:107605.
    >> Share

    April 2024
  160. GOTO T, Hernandez CG, Tsujimoto Y, Kitagawa T, et al
    Are biologics effective on lung hyperinflation in patients with resistant asthma?
    Respir Med. 2024 Apr 30:107652. doi: 10.1016/j.rmed.2024.107652.
    >> Share

  161. CAZZOLA M, Maniscalco M
    Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply.
    Respir Med. 2024 Apr 26:107653. doi: 10.1016/j.rmed.2024.107653.
    >> Share

  162. JI H, Tan LD, Hafzella G, Nguyen N, et al
    Navigating Biologic Therapies in Elderly Asthma.
    Respir Med. 2024 Apr 26:107655. doi: 10.1016/j.rmed.2024.107655.
    >> Share

  163. CANONICA GW, Domingo C, Lavoie KL, Kaliasethi A, et al
    Asthma patients' and physicians' perspectives on the burden and management of asthma: post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence.
    Respir Med. 2024 Apr 16:107637. doi: 10.1016/j.rmed.2024.107637.
    >> Share

  164. ROBERTS MH, Duh MS, Rothnie KJ, Zhang S, et al
    Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
    Respir Med. 2024 Apr 7:107630. doi: 10.1016/j.rmed.2024.107630.
    >> Share

  165. SHENG DUH M, Roberts MH, Rothnie KJ, Cheng WY, et al
    Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: a retrospective US claims study.
    Respir Med. 2024 Apr 7:107629. doi: 10.1016/j.rmed.2024.107629.
    >> Share

  166. MONDAL P, Lopez SP, Khokhar A, Snyder D, et al
    The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.
    Respir Med. 2024;224:107564.
    >> Share

  167. MAROTT JL, Ingebrigtsen TS, Colak Y, Vestbo J, et al
    Predicting exacerbations in COPD in the Danish general population.
    Respir Med. 2024;224:107557.
    >> Share

  168. KOH LHL, Sims JL, Pepin F, Wilsher M, et al
    Role of screening for uveitis in subjects with sarcoidosis.
    Respir Med. 2024;224:107562.
    >> Share

  169. DE BORTOLI A, Dawson KA, Hashem D, Spence SD, et al
    Screening tools for the detection of clinically silent cardiac sarcoidosis.
    Respir Med. 2024;224:107538.
    >> Share

  170. XU X, Yin J, Yang Y, Liu H, et al
    Advances in co-pathogenesis of the united airway diseases.
    Respir Med. 2024;225:107580.
    >> Share

    March 2024
  171. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
    A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting beta(2)-agonist reliever or ICS/formoterol reliever only in mild asthma.
    Respir Med. 2024 Mar 30:107610. doi: 10.1016/j.rmed.2024.107610.
    >> Share

  172. JEONG J, Nam YH, Sim DW, Kim BK, et al
    Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma.
    Respir Med. 2024;225:107598.
    >> Share

  173. WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Weersink EJM, et al
    Exhaled breath analyses for bronchial thermoplasty in severe asthma patients.
    Respir Med. 2024 Mar 4:107583. doi: 10.1016/j.rmed.2024.107583.
    >> Share

    February 2024
  174. MANISCALCO M, Candia C, Calabrese C, D'Amato M, et al
    Impact of biologics on lung hyperinflation in patients with severe asthma.
    Respir Med. 2024 Feb 29:107578. doi: 10.1016/j.rmed.2024.107578.
    >> Share

  175. ALMQVIST L, Andersson M, Backman H, Ronmark E, et al
    No remission in 60% of those with childhood-onset asthma - A population-based cohort followed from 8 to 28 years of age.
    Respir Med. 2024 Feb 26:107581. doi: 10.1016/j.rmed.2024.107581.
    >> Share

    January 2024
  176. PAPI A, Castro M, Corren J, Pavord ID, et al
    Dupilumab sustains lung function improvements in patients with moderate-to-severe asthma.
    Respir Med. 2024 Jan 23:107535. doi: 10.1016/j.rmed.2024.107535.
    >> Share

    November 2023
  177. LAVORINI F, Usmani OS, Salvi S, Rote K, et al
    A narrative review on the Synchrobreathe: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
    Respir Med. 2023;219:107435.
    >> Share

    October 2023
  178. KOSTIKAS K, Maspero JF, Chapman KR, Mezzi K, et al
    Efficacy of mometasone/indacaterol/glycopyrronium in patients with inadequately controlled asthma with respect to baseline eosinophil count: Post hoc analysis of IRIDIUM study.
    Respir Med. 2023;217:107334.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016